Core Insights - Nanjing Normal University Changzhou Synthetic Biology Industry Research Institute has been approved as Jiangsu Province's Synthetic Biotechnology Innovation Center, marking a significant step for Changzhou in the synthetic biology sector and injecting new momentum into regional economic development [1][3] Group 1: Innovation Center Development - The innovation center focuses on the life and health industry, establishing two foundational infrastructure platforms: "intelligent machine learning design" and "high-throughput quantitative analysis testing," along with four key technology R&D platforms and one incubation and service platform [3] - The center aims to integrate technology, capital, and industry elements to support high-quality development of the synthetic biology industry in the region [3] Group 2: Strategic Goals and Future Plans - Changzhou High-tech Zone has strategically positioned itself in the life and health industry since 2010, leveraging its strong manufacturing base and complete industrial system to foster the development of the synthetic biology sector [3] - By 2024, the Changzhou High-tech Zone is expected to be approved as a provincial pilot for future industry aggregation, with plans to introduce and incubate nearly 10 enterprises and sign 22 new synthetic biology projects by 2025 [3][4] - The goal for 2027 is to achieve a "1+123" development target, which includes creating one national-level innovation platform, gathering 100 high-quality synthetic biology enterprises, and reaching a market valuation of 20 billion and an output value of 30 billion [4]
常州合成生物学产业研究院晋级“省级创新中心”
Yang Zi Wan Bao Wang·2025-10-29 08:06